John P Leonard

Evaluation of a REDCap-based Workflow for Supporting Federal Guidance for Electronic Informed Consent.

Cindy Chen, Scott W. Brown, Thomas R Campion, 2019, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

Establishing the Feasibility of a Tablet-Based Consent Process with Older Adults: A Mixed-Methods Study

Katarzyna Wyka, John P Leonard, M. C. Reid, 2019, The Gerontologist.

Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma.

Bruce D Cheson, John P Leonard, J. Leonard, 2008, The New England journal of medicine.

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Ronald Levy, John P Leonard, Patrick B Johnston, 2010, Blood.

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.

John P Leonard, J. Leonard, A. Younes, 2010, The New England journal of medicine.

Pilot Study of Aurora, a Social, Mobile-Phone-Based Emotion Sharing and Recording System

Geri Gay, Phil Adams, John P Leonard, 2011, Journal of diabetes science and technology.

A role for caspase-1 and -3 in the pathology of experimental allergic encephalomyelitis : inflammation versus degeneration.

John P Leonard, J. Leonard, M. Cuzner, 2002, The American journal of pathology.

Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma

Roland Schmitz, Bao Tran, Yongmei Zhao, 2018, The New England journal of medicine.

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma.

Yoonjin Cho, John P Leonard, R. Ulrich, 2014, Blood.